In vivo immunization following virus suppression: A novel approach for inducing immune control in chronic hepatitis B

Journal of Viral Hepatitis

Volumn 10, Issue 1, 2003, Pages 7-9

  Sprengers, D ^b   Janssen, H L A ^b   Kwekkeboom, J ^b   Niesters, H G M ^b   De Man, R A ^b   Schalm, S W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Chronic hepatitis B; Combination therapy; Interferon alpha; Lamivudine; Treatment interruption

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; LAMIVUDINE; NUCLEOSIDE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHRONIC HEPATITIS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHRONIC DISEASE; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B; HUMANS; IMMUNIZATION; INTERFERON-ALPHA; LAMIVUDINE; VIRUS REPLICATION;

EID: 0345237925     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00395.x     Document Type: Review

References (9)

1. Schalm SW, Heathcote J, Cianciara J et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000; 46: 562-568.
2. Barbaro G, Zechini F, Pellicelli AM et al. Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. J Hepatol 2001; 35: 406-411.
3. van Nunen AB, Hansen BE, Mutimer DJ, Niesters HG, de Man RA, Schalm SW. Viral kinetics during 16 weeks of interferon and lamivudine monotherapy versus interferon-lamivudine combination therapy in chronic hepatitis B patients. Hepatology 2000; 32: 379A.
4. Boni C, Penna A, Ogg G et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963-971.
5. Carcelain G, Tubiana R, Samri A et al. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebound during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol 2001; 75: 234-241.
6. Kao JH, Chen PJ, Lai MY, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology 2001; 34: 817-823.
7. Michel M-L, Pol S, Brechot C, Tiollais P. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future. Vaccine 2001; 19: 2395-2399.
8. Heathcote J, McHutchison J, Lee S et al. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group. Hepatology 1999; 30: 531-536.
9. Rehermann B, Fowler P, Sidney J et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-1058.